Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Reperfusion Injury: full-pipeline trial registry
1 of 5 indexed Reperfusion Injury trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Reperfusion Injury: 5 US clinical trials tracked, 1 recruiting.
Reperfusion Injury is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Stealth BioTherapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition reperfusion-injury
OPEN 1 | RECR 20% | LATE 2 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Reperfusion Injury lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Reperfusion Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Reperfusion Injury is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Reperfusion Injury research.
Stealth BioTherapeutics accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Reperfusion Injury enrolment sits around 150 participants.
Median target enrolment is 150 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Reperfusion Injury research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Hydrogen's Feasibility and Safety as a Therapy in ECPR
Boston Children's Hospital
NCT05574296
Goal-directed CPR Using Cerebral Oximetry
NYU Langone Health
NCT04924985
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
Medicure
NCT00402506
Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
Stealth BioTherapeutics
NCT01572909
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Rutgers, The State University of New Jersey
NCT01167569
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Reperfusion Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Reperfusion Injury trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Reperfusion Injury page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Reperfusion Injury trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Stealth BioTherapeutics sponsors the most Reperfusion Injury trials on record, review their full trial history before evaluating a specific study. See Stealth BioTherapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Reperfusion Injury condition card totals 5 registered trials; most-linked intervention (MC-1) Pyridoxal 5'-phosphate; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.